大博医疗(002901) - 2024 Q1 - 季度财报

Revenue and Profit - The total revenue for the first quarter was 12,368,610.28 CNY, with a significant government subsidy of 13,849,369.86 CNY impacting the financial results positively [5]. - The total net profit for the first quarter was 67,201,457.82 yuan, an increase of 7.00% compared to 62,745,150.49 yuan in the same period last year [23]. - Revenue from sales of goods and services received cash of 465,773,219.88 yuan, representing a 30.32% increase from 357,397,127.42 yuan year-on-year [23]. - The total operating revenue for the current period is ¥427,279,900.69, representing a 9.17% increase compared to ¥391,374,553.00 in the same period last year [44]. - The net profit attributable to shareholders of the listed company is ¥61,728,900.60, up 6.05% from ¥58,209,336.93 year-on-year [44]. - The company's operating profit for the quarter was 76,555,082.59 yuan, up from 65,971,925.55 yuan in the previous year, marking a growth of 8.00% [23]. Cash Flow and Investments - Cash received from investment income increased by 30.06% to 4,199,276.19 CNY, attributed to higher financial product returns [7]. - The net cash flow from investment activities was -152,951,560.73 CNY, indicating a decrease compared to the previous period [15]. - The cash flow from financing activities resulted in a net outflow of -52,825,949.18 CNY, contrasting with a net inflow in the previous period [15]. - The net cash flow from operating activities is ¥52,671,456.22, a significant improvement of 151.94% compared to a negative cash flow of ¥101,409,485.52 in the previous year [44]. - Cash inflow from operating activities rose to ¥491,372,082.02, up from ¥422,674,353.52, marking an increase of approximately 16.2% [54]. Assets and Liabilities - The total current assets amounted to 3,091,003,678.66 CNY, with inventory valued at 1,198,071,796.20 CNY [11]. - The company’s total assets increased by 40.29% to 607,730,396.75 yuan, primarily due to increased bank wealth management purchases [23]. - The total assets at the end of the reporting period amount to ¥4,618,933,142.40, a slight decrease of 0.45% from ¥4,639,740,860.70 at the end of the previous year [44]. - The total liabilities decreased from ¥1,479,079,740.59 to ¥1,391,402,855.50, representing a reduction of approximately 5.9% [52]. - The total current liabilities decreased to ¥1,075,049,947.75 from ¥1,153,674,553.92 in the previous year [38]. Shareholder Returns and Equity - The company reported a 3430.65% increase in cash paid for dividends, totaling 21,142,636.08 CNY, reflecting a significant distribution to shareholders [7]. - The equity attributable to shareholders of the listed company increased to ¥3,118,320,794.12, reflecting a 1.96% growth from ¥3,058,491,836.78 [44]. - The total equity increased from ¥3,160,661,120.11 to ¥3,227,530,286.90, reflecting a growth of about 2.1% [52]. - The company's retained earnings increased from ¥1,275,854,472.69 to ¥1,337,583,373.29, showing a growth of about 4.8% [52]. Expenses and Impairments - The company reported a significant increase in financial expenses, with a rise of 127.02% to 4,718,941.98 yuan due to increased interest expenses and foreign exchange losses [23]. - The accounts receivable impairment loss decreased by 394.58%, amounting to 2,966,999.15 yuan, indicating improved collection of long-aged accounts [23]. - The company’s tax expenses rose by 175.49% to 8,794,923.09 yuan, reflecting an increase in total profit [23]. - The company’s R&D expenses for the current period are ¥59,950,671.27, down from ¥63,032,915.87 in the previous year [39]. Other Financial Metrics - The cash and cash equivalents at the end of the period stood at 129,711,280.37 CNY, down from 277,164,148.92 CNY at the beginning of the period [15]. - The company has not undergone an audit for the first quarter report, indicating that the figures are unaudited [16]. - The basic earnings per share for the current period is ¥0.15, which is a 7.14% increase from ¥0.14 in the same period last year [44]. - The weighted average return on net assets is 2.00%, an increase of 0.08 percentage points from 1.92% in the previous year [44]. - The total comprehensive income for the period was ¥66,869,167.79, compared to ¥63,262,234.71, indicating an increase of about 4.1% [62].